Proteome Sciences Providing Biomarker Services to Eisai

Under a deal announced today, Proteome Sciences will measure candidate biomarkers for Alzheimer's disease for Eisai.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.